Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma.

MLA

Abeykoon, Jithma P., et al. “Implications of Detecting Serum Monoclonal Protein by MASS-Fix Following Stem Cell Transplantation in Multiple Myeloma.” British Journal of Haematology, vol. 193, no. 2, Apr. 2021, pp. 380–85. EBSCOhost, https://doi.org/10.1111/bjh.17195.

APA

Abeykoon, J. P., Murray, D. L., Murray, I., Jevremovic, D., Otteson, G. E., Dispenzieri, A., Arendt, B. K., Dasari, S., Gertz, M., Gonsalves, W. I., Kourelis, T. V., Muchtar, E., Dingli, D., Warsame, R., Go, R. S., Lacy, M. Q., Leung, N., Buadi, F., Lin, Y., … Kapoor, P. (2021). Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma. British Journal of Haematology, 193(2), 380–385. https://doi.org/10.1111/bjh.17195

Chicago

Abeykoon, Jithma P, David L Murray, Isaiah Murray, Dragan Jevremovic, Gregory E Otteson, Angela Dispenzieri, Bonnie K Arendt, et al. 2021. “Implications of Detecting Serum Monoclonal Protein by MASS-Fix Following Stem Cell Transplantation in Multiple Myeloma.” British Journal of Haematology 193 (2): 380–85. doi:10.1111/bjh.17195.